tiprankstipranks
Biora Therapeutics (DE:4ZU)
FRANKFURT:4ZU

Biora Therapeutics (4ZU) Stock Investors

0 Followers
Based on 599,614 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.2% of all portfolios hold DE:4ZU
On average, investors allocate 3.26% of their portfolios to DE:4ZU
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 4ZU

5.6%
Last 7
Days
8.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:4ZU, out of 599,614 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

4ZU Investor Activity

No data currently available
Based on the activity of 11,387 investors who made their portfolios public
The table shows changes in 4ZU in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

4ZU Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
BioNano Genomics
4.38%
-4.69%
-5.54%
433.51M
Healthcare
SNDL
4.02%
-5.24%
-6.35%
503.96M
Basic Materials
Fisker
4.34%
-4.67%
-4.40%
2.21B
Consumer Goods
Skillz
2.72%
-5.10%
-6.47%
218.81M
Technology
Virgin Galactic Holdings
4.10%
-5.08%
-6.26%
1.01B
Technology
Peloton Interactive
3.11%
-4.93%
-6.30%
3.03B
Services
fuboTV
3.20%
-5.12%
-6.77%
341.82M
Technology
AMC Entertainment
6.50%
-5.18%
-5.99%
2.01B
Services
Novavax
4.29%
-4.11%
-4.49%
936.74M
Healthcare
General Electric
5.62%
-3.21%
-1.21%
78.61B
Industrial Goods
Based on the activity of 599,614 active portfolios
Open your Smart Portfolio

4ZU Investor Analysis

DE:4ZU investors under 35

Under 35

5.7%
Last 30 days
Holdings Change
19.2%
of DE:4ZU holders
are under 35
Average Segment Performance
Average P/E Ratio12.12
Beta5.31
Dividend Yield4.87%
DE:4ZU investors between 35–55

Between 35–55

20.6%
Last 30 days
Holdings Change
56.8%
of DE:4ZU holders
are between 35–55
Average Segment Performance
Average P/E Ratio10.48
Beta1.03
Dividend Yield5.62%
DE:4ZU investors over 55

Over 55

13.1%
Last 30 days
Holdings Change
24.0%
of DE:4ZU holders
are over 55
Average Segment Performance
Average P/E Ratio10.07
Beta0.90
Dividend Yield4.85%
Overview of age group and performance of DE:4ZU stock investors
See who invests in 4ZU according to age group and performance.

FAQ

How many retail Investors hold DE:4ZU?
0.2% of TipRanks' retail investors hold DE:4ZU in their portfolios.
    What is DE:4ZU Investor Sentiment?
    DE:4ZU’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DE:4ZU in the last 7 days?
      ▼ 5.6% of TipRanks' retail investors changed their holding of DE:4ZU in the last 7 days.
        What percentage of retail investors changed their holding of DE:4ZU in the last 30 days?
        ▼ 8.3% of TipRanks' retail investors changed their holding of DE:4ZU in the last 30 days.
          What is the average age of retail investors who hold DE:4ZU?
          The average age of DE:4ZU Holders is between 35–55.
            What other stocks have DE:4ZU investors also bought?
            DE:4ZU Investors also bought BNGO, SNDL, FSR, SKLZ, SPCE, PTON, FUBO, AMC, NVAX, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALNYAlnylam Pharma
              AMGNAmgen
              SEELSeelos Therapeutics
              BIOBio-Rad Laboratories
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis